EA201790897A1 - Способы полусинтеза - Google Patents
Способы полусинтезаInfo
- Publication number
- EA201790897A1 EA201790897A1 EA201790897A EA201790897A EA201790897A1 EA 201790897 A1 EA201790897 A1 EA 201790897A1 EA 201790897 A EA201790897 A EA 201790897A EA 201790897 A EA201790897 A EA 201790897A EA 201790897 A1 EA201790897 A1 EA 201790897A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salt
- substituted
- substituted tetracycline
- methods
- hexafluoroarsenate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 hexafluorophosphate Chemical compound 0.000 abstract 7
- 239000004098 Tetracycline Substances 0.000 abstract 6
- 235000019364 tetracycline Nutrition 0.000 abstract 6
- 150000003522 tetracyclines Chemical class 0.000 abstract 5
- 229960002180 tetracycline Drugs 0.000 abstract 4
- 229930101283 tetracycline Natural products 0.000 abstract 4
- 238000003682 fluorination reaction Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 229940040944 tetracyclines Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 239000000543 intermediate Chemical class 0.000 abstract 1
- 239000002608 ionic liquid Substances 0.000 abstract 1
- 239000003495 polar organic solvent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/20—Diazonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462067697P | 2014-10-23 | 2014-10-23 | |
| PCT/US2015/057167 WO2016065290A1 (en) | 2014-10-23 | 2015-10-23 | Semi-synthesis procedures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201790897A1 true EA201790897A1 (ru) | 2017-08-31 |
Family
ID=54478255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201790897A EA201790897A1 (ru) | 2014-10-23 | 2015-10-23 | Способы полусинтеза |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10087157B2 (enExample) |
| EP (1) | EP3209642A1 (enExample) |
| JP (1) | JP2017533203A (enExample) |
| CN (1) | CN107108472B (enExample) |
| AU (1) | AU2015335661A1 (enExample) |
| CA (1) | CA2964957A1 (enExample) |
| EA (1) | EA201790897A1 (enExample) |
| MA (1) | MA40836A (enExample) |
| MX (1) | MX369167B (enExample) |
| WO (1) | WO2016065290A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA031523B1 (ru) | 2012-08-31 | 2019-01-31 | Тетрафейз Фармасьютикалс, Инк. | Тетрациклиновые соединения |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
| WO2017097891A1 (en) | 2015-12-10 | 2017-06-15 | Sandoz Ag | Crystalline eravacycline |
| CN107759503A (zh) * | 2016-08-16 | 2018-03-06 | 四川科伦博泰生物医药股份有限公司 | 一种四环素衍生物及其用途 |
| HRP20240605T1 (hr) * | 2016-10-19 | 2024-07-19 | Tetraphase Pharmaceuticals, Inc. | Kristalni oblici eravaciklina |
| CN111362829B (zh) * | 2018-12-26 | 2021-11-30 | 浙江昌海制药有限公司 | 一种米诺环素二对氯苯磺酸盐晶型及其制备方法和应用 |
| CN109734668B (zh) * | 2019-03-08 | 2020-06-23 | 杭州华樾新材料有限公司 | 四氟硼酸盐离子液体的合成方法 |
| CN110156624B (zh) * | 2019-05-29 | 2022-03-08 | 河北冀衡药业股份有限公司 | 一种米诺环素及其衍生物的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB935384A (en) * | 1959-03-30 | 1963-08-28 | Pfizer & Co C | Tetracycline derivatives and preparation thereof |
| US3239499A (en) | 1961-05-19 | 1966-03-08 | Pfizer & Co C | Tetracycline derivative |
| AU2002341970B2 (en) | 2001-10-05 | 2008-02-14 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives and methods of use thereof |
| CN105367440A (zh) | 2008-08-08 | 2016-03-02 | 四相制药公司 | C7-氟取代的四环素化合物 |
| EP2424834B1 (en) | 2009-04-30 | 2018-07-11 | President and Fellows of Harvard College | Synthesis of tetracyclines and intermediates thereof |
| HUE037852T2 (hu) * | 2009-08-28 | 2018-09-28 | Tetraphase Pharmaceuticals Inc | Tetraciklin-vegyületek |
| PL2552890T3 (pl) * | 2010-03-31 | 2017-07-31 | Tetraphase Pharmaceuticals, Inc. | Policykliczne związki tetracyklinowe |
| WO2012047907A1 (en) * | 2010-10-04 | 2012-04-12 | President And Fellows Of Harvard College | Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
-
2015
- 2015-10-22 MA MA040836A patent/MA40836A/fr unknown
- 2015-10-23 AU AU2015335661A patent/AU2015335661A1/en not_active Abandoned
- 2015-10-23 MX MX2017005223A patent/MX369167B/es active IP Right Grant
- 2015-10-23 EP EP15791440.9A patent/EP3209642A1/en not_active Withdrawn
- 2015-10-23 US US15/521,162 patent/US10087157B2/en not_active Expired - Fee Related
- 2015-10-23 CN CN201580070869.6A patent/CN107108472B/zh not_active Expired - Fee Related
- 2015-10-23 WO PCT/US2015/057167 patent/WO2016065290A1/en not_active Ceased
- 2015-10-23 CA CA2964957A patent/CA2964957A1/en not_active Abandoned
- 2015-10-23 EA EA201790897A patent/EA201790897A1/ru unknown
- 2015-10-23 JP JP2017521573A patent/JP2017533203A/ja active Pending
-
2018
- 2018-08-09 US US16/059,857 patent/US10618879B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017005223A (es) | 2017-06-21 |
| CN107108472B (zh) | 2020-03-13 |
| JP2017533203A (ja) | 2017-11-09 |
| CN107108472A (zh) | 2017-08-29 |
| US20190210988A1 (en) | 2019-07-11 |
| EP3209642A1 (en) | 2017-08-30 |
| AU2015335661A1 (en) | 2017-05-04 |
| MA40836A (fr) | 2017-08-29 |
| WO2016065290A1 (en) | 2016-04-28 |
| US20170334872A1 (en) | 2017-11-23 |
| US10087157B2 (en) | 2018-10-02 |
| US10618879B2 (en) | 2020-04-14 |
| MX369167B (es) | 2019-10-30 |
| CA2964957A1 (en) | 2016-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790897A1 (ru) | Способы полусинтеза | |
| CY1123164T1 (el) | Διεργασια για τη συνθεση ενος αναστολεα ινδολαμινης 2,3-διοξυγενασης | |
| EA201792535A1 (ru) | Гетероциклические амиды в качестве ингибиторов киназ | |
| EA201890522A1 (ru) | Способ получения противогрибковых соединений | |
| PH12018500718A1 (en) | Compounds useful as modulators of trpm8 | |
| EA201892147A1 (ru) | Бициклические соединения | |
| EA201691649A1 (ru) | Способ получения противогрибковых соединений | |
| EA201892485A1 (ru) | Способ получения соединения диарилтиогидантоина | |
| EA201891264A2 (ru) | Антагонисты st2l и способы их применения | |
| EA201691648A1 (ru) | Способ получения противогрибковых соединений | |
| EA201691906A1 (ru) | Способы получения циклических и ациклических кетонов | |
| EA201890329A1 (ru) | СОЕДИНЕНИЯ В КАЧЕСТВЕ МОДУЛЯТОРОВ RORγ | |
| CY1117100T1 (el) | Συμπλοκο υδραλογονου της αγομελατινης και μεθοδος παρασκευης του | |
| EA202091259A1 (ru) | Способ получения опикапона и его интермедиатов | |
| EA201790983A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| EA201591349A1 (ru) | Способ получения вортиоксетина | |
| EA201890434A1 (ru) | Антитела к cd154 и способы их применения | |
| EA201690696A1 (ru) | Способ получения адамантанамидов | |
| EA201892624A1 (ru) | Растения, дающие бессемянные плоды | |
| EA201692288A1 (ru) | Способ получения фосфорсодержащих циангидринов | |
| EA201790496A1 (ru) | Соединения 1-алкил-6-оксо-1,6-дигидропиридин-3-ила и применение в качестве модуляторов sgrm | |
| PT3784649T (pt) | Processo de síntese do ácido (s)-3-amino-4-(difluorometilenil)ciclopent-1-eno-1-carboxílico | |
| EA201591530A1 (ru) | Новая соль абексиностата, соответствующая кристаллическая форма, способ ее получения и содержащие ее фармацевтические композиции | |
| EA201790445A1 (ru) | Производные индолинона и их применение | |
| EA201600494A1 (ru) | Бензамидные и никотинамидные соединения и способы их применения |